JCI - Citations to Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma.

Citations to this article

Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma.

H Imai, … , X D Fu, E M Tan

H Imai, … , X D Fu, E M Tan

Published November 1, 1993
Citation Information: J Clin Invest. 1993;92(5):2419-2426. https://doi.org/10.1172/JCI116848.

View: Text | PDF

Research Article

Total citations by year

Year:	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1960	Total
Citations:	3	3	1	2	5	2	3	3	9	4	3	9	4	4	2	3	5	4	3	1	3	7	4	3	6	3	3	3	3	1	109

Citation information

Citations to this article (109)

Title and authors	Publication	Year
Cooperative condensation of RNA-DIRECTED DNA METHYLATION 16 splicing isoforms enhances heat tolerance in Arabidopsis Ma J, Li S, Wang T, Tao Z, Huang S, Lin N, Zhao Y, Wang C, Li P	Nature Communications	2025
RBM39 Functions as a Potential Oncogene Through the NF-κB Signaling Pathway in Colorectal Cancer Cells Wang Y, Yang X, Yang Z, Chen Z, Jiang H, Wang Y, Shen D, Su G	Journal of Cancer	2025
RBM39 shapes innate immunity by controlling the expression of key factors of the interferon response Li TF, Rothhaar P, Lang A, Grünvogel O, Colasanti O, Ugarte SM, Traut J, Piras A, Acosta-Rivero N, Gonçalves Magalhães V, Springer E, Betz A, Huang HE, Park J, Qiu R, Gnouamozi GE, Mehnert AK, Thi VL, Urban S, Muckenthaler M, Schlesner M, Wohlleber D, Binder M, Bartenschlager R, Pichlmair A, Lohmann V	Frontiers in Immunology	2025
Recent advances in anticancer mechanisms of molecular glue degraders: focus on RBM39-dgrading synthetic sulfonamide such as indisulam, E7820, tasisulam, and chloroquinoxaline sulfonamide. Jang JH, Kim JY, Lee TJ	Genes & genomics	2024
Eng Meng Tan. Chan EKL, Pollard KM, Fritzler MJ	Annals of the rheumatic diseases	2024
Targeting RBM39 suppresses tumor growth and sensitizes osteosarcoma cells to cisplatin. Wang J, Zheng L, Chen W, Zhang X, Lv D, Zeng C, Zhang C, Zhang R, Kang T, Zhong L	Oncogene	2024
Therapeutic Targeting of RNA Splicing in Cancer Bonner EA, Lee SC	Genes & development	2023
Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization. Zhang J, Guo X, Jin B, Zhu Q	Frontiers in Oncology	2022
Systematic pan-cancer analysis identifies RBM39 as an immunological and prognostic biomarker. Zhang R, Wang W, Zhang N, Chen X, Liu W, Zhang L, Liu N	Journal of Cellular and Molecular Medicine	2022
RNA‐binding motif protein 39 (RBM39): An emerging cancer target Y Xu, A Nijhuis, HC Keun	British Journal of Pharmacology	2021
RNA-binding protein 39: a promising therapeutic target for cancer C Xu, X Chen, X Zhang, D Zhao, Z Dou, X Xie, H Li, H Yang, Q Li, H Zhang, C Di	Cell Death Discovery	2021
An Autoantigen-ome from HS-Sultan B-Lymphoblasts Offers a Molecular Map for Investigating Autoimmune Sequelae of COVID-19. Wang JY, Zhang W, Roehrl VB, Roehrl MW, Roehrl MH	bioRxiv : the preprint server for biology	2021
A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases. Wang JY, Roehrl MW, Roehrl VB, Roehrl MH	bioRxiv : the preprint server for biology	2021
An Autoantigen Profile from Jurkat T-Lymphoblasts Provides a Molecular Guide for Investigating Autoimmune Sequelae of COVID-19. Wang JY, Zhang W, Roehrl MW, Roehrl VB, Roehrl MH	bioRxiv : the preprint server for biology	2021
An exon skipping screen identifies antitumor drugs that are potent modulators of pre-mRNA splicing, suggesting new therapeutic applications Y Shi, W Bray, AJ Smith, W Zhou, J Calaoagan, C Lagisetti, L Sambucetti, P Crews, RS Lokey, TR Webb, M Spies	PloS one	2020
Tyramide signal amplification mass spectrometry (TSA-MS) ratio identifies nuclear speckle proteins J Dopie, MJ Sweredoski, A Moradian, AS Belmont	The Journal of Cell Biology	2020
RNA Regulators in Leukemia and Lymphoma C Prieto, MG Kharas	Cold Spring Harbor Perspectives in Medicine	2019
Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia E Wang, SX Lu, A Pastore, X Chen, J Imig, SC Lee, K Hockemeyer, YE Ghebrechristos, A Yoshimi, D Inoue, M Ki, H Cho, L Bitner, A Kloetgen, KT Lin, T Uehara, T Owa, R Tibes, AR Krainer, O Abdel-Wahab, I Aifantis	Cancer Cell	2019
A repertoire of 124 potential autoantigens for autoimmune kidney diseases identified by dermatan sulfate affinity enrichment of kidney tissue proteins W Zhang, J Rho, MW Roehrl, MH Roehrl, JY Wang, JC Crispin	PloS one	2019
Early detection of hepatocellular carcinoma using autoantibody profiles from a panel of tumor-associated antigens JA Koziol, H Imai, L Dai, JY Zhang, EM Tan	Cancer Immunology, Immunotherapy	2018
PUF60-activated exons uncover altered 3′ splice-site selection by germline missense mutations in a single RRM J Královičová, I Ševčíková, E Stejskalová, M Obuća, M Hiller, D Staněk, I Vořechovský	Nucleic Acids Research	2018
Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer: WANG et al P Wang, J Qin, H Ye, L Li, X Wang, J Zhang	Journal of Cellular Biochemistry	2018
Dr Eng M. Tan: a tribute to an enduring legacy in autoimmunity MJ Fritzler, EK Chan	Lupus	2017
Autoantibodies: Opportunities for Early Cancer Detection IK Macdonald, CB Parsy-Kowalska, CJ Chapman	Trends in Cancer	2017
Tracing and Characterizing the Development of Transplanted Female Germline Stem Cells In Vivo C Wu, B Xu, X Li, W Ma, P Zhang, X Chen, J Wu	Molecular Therapy	2017
Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer H Sun, JX Shi, HF Zhang, MT Xing, P Li, LP Dai, CL Luo, X Wang, P Wang, H Ye, LX Li, JY Zhang	Tumor Biology	2017
Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer P Li, JX Shi, MT Xing, LP Dai, JT Li, JY Zhang	Tumor Biology	2017
Serologic autoantibodies against tumor associated antigens as potential biomarkers in patients suffering from Hepatocellular carcinoma and Cholangiocarcinoma MZ Mustafa, Z Tanveer, Asadullah, A Attique, M Asif, F Rehman, S Babar, I Ali, M Rasool, JC Duclos-Vallee, E Ballot		2017
Selective degradation of splicing factor CAPERα by anticancer sulfonamides T Uehara, Y Minoshima, K Sagane, NH Sugi, KO Mitsuhashi, N Yamamoto, H Kamiyama, K Takahashi, Y Kotake, M Uesugi, A Yokoi, A Inoue, T Yoshida, M Mabuchi, A Tanaka, T Owa	Nature Chemical Biology	2017
Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15 T Han, M Goralski, N Gaskill, E Capota, J Kim, TC Ting, Y Xie, NS Williams, D Nijhawan	Science	2017
Selective degradation of splicing factor CAPERα by anticancer sulfonamides. Uehara T, Minoshima Y, Sagane K, Sugi NH, Mitsuhashi KO, Yamamoto N, Kamiyama H, Takahashi K, Kotake Y, Uesugi M, Yokoi A, Inoue A, Yoshida T, Mabuchi M, Tanaka A, Owa T	Nature Chemical Biology	2017
Tumor-associated antigen CAPERα and microvessel density in hepatocellular carcinoma L Dai, XX Peng, EM Tan, JY Zhang	Oncotarget	2016
UHM–ULM interactions in the RBM39–U2AF65 splicing-factor complex GA Stepanyuk, P Serrano, E Peralta, CL Farr, HL Axelrod, M Geralt, D Das, HJ Chiu, L Jaroszewski, AM Deacon, SA Lesley, MA Elsliger, A Godzik, IA Wilson, K Wüthrich, DR Salomon, JR Williamson	Acta Crystallographica Section D-Structural Biology	2016
Autoantibodies against tumor-associated antigens in the early detection of lung cancer L Dai, JC Tsay, J Li, TA Yie, JS Munger, H Pass, WN Rom, Y Zhang, EM Tan, JY Zhang	Lung Cancer	2016
Global regulation of alternative RNA splicing by the SR-rich protein RBM39 S Mai, X Qu, P Li, Q Ma, C Cao, X Liu	Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms	2016
ERRβ splice variants differentially regulate cell cycle progression MM Heckler, RB Riggins	Cell cycle (Georgetown, Tex.)	2015
Conserved RNA-Binding Proteins Required for Dendrite Morphogenesis in Caenorhabditis elegans Sensory Neurons S Antonacci, D Forand, M Wolf, C Tyus, J Barney, L Kellogg, MA Simon, G Kerr, KL Wells, S Younes, NT Mortimer, EC Olesnicky, DJ Killian	G3: Genes\|Genomes\|Genetics	2015
Autoantibodies against tumor-associated antigens for detection of hepatocellular carcinoma Y Hong	World journal of hepatology	2015
Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma L Dai, P Ren, M Liu, H Imai, EM Tan, JY Zhang	Clinical Immunology	2014
Preferential autoimmune response in prostate cancer to cyclin b1 in a panel of tumor-associated antigens L Dai, J Li, R Ortega, W Qian, CA Casiano, JY Zhang	Journal of Immunology Research	2014
Overexpression of HCC1/CAPERα may play a role in lung cancer carcinogenesis Y Chai, X Liu, L Dai, Y Li, M Liu, JY Zhang	Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine	2014
Antinuclear antibodies defining autoimmunity pathways EM Tan	Arthritis Research & Therapy	2014
CAPER, a novel regulator of human breast cancer progression I Mercier, DM Gonzales, K Quann, TG Pestell, A Molchansky, F Sotgia, J Hulit, R Gandara, C Wang, RG Pestell, MP Lisanti, JF Jasmin	Cell cycle (Georgetown, Tex.)	2014
Coordinated control of senescence by lncRNA and a novel T-box3 co-repressor complex PK P, U Emechebe, R Smith, S Franklin, B Moore, M Yandell, SL Lessnick, AM Moon, MR Green	eLife	2014
Restricted Boltzmann Machines for Classification of Hepatocellular Carcinoma JA Koziol, EM Tan, L Dai, P Ren, JY Zhang	Computational Biology Journal	2014
Mechanisms for U2AF to define 3′ splice sites and regulate alternative splicing in the human genome C Shao, B Yang, T Wu, J Huang, P Tang, Y Zhou, J Zhou, J Qiu, L Jiang, H Li, G Chen, H Sun, Y Zhang, A Denise, DE Zhang, XD Fu	Nature Structural & Molecular Biology	2014
Cancer-relevant Splicing Factor CAPERα Engages the Essential Splicing Factor SF3b155 in a Specific Ternary Complex S Loerch, A Maucuer, V Manceau, MR Green, CL Kielkopf	The Journal of biological chemistry	2014
Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis Q Zhu, M Liu, L Dai, X Ying, H Ye, Y Zhou, S Han, JY Zhang	Autoimmunity Reviews	2013
Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC) L Dai, N Lei, M Liu, JY Zhang	Experimental Hematology and Oncology	2013
RNA-binding proteins and translational regulation in axons and growth cones H Hörnberg, C Holt	Frontiers in neuroscience	2013
A New ELISA for Dermatomyositis Autoantibodies: Rapid Introduction of Autoantigen cDNA to Recombinant Assays for Autoantibody Measurement Y Muro, K Sugiura, M Akiyama	Clinical and Developmental Immunology	2013
Autoantibodies, autoimmune disease, and the birth of immune diagnostics Eng M. Tan	Journal of Clinical Investigation	2012
Elevated serum antibodies against insulin-like growth factor-binding protein-2 allow detecting early-stage cancers: evidences from glioma and colorectal carcinoma studies Y Li, T Jiang, J Zhang, B Zhang, W Yang, G You, K Xu, J Wu, C Luo, SW Song	Annals of Oncology	2012
Interacting factors and cellular localization of SR protein-specific kinase Dsk1 Z Tang, M Luca, L Taggart-Murphy, J Portillio, C Chang, A Guven, RJ Lin, J Murray, A Carr	Experimental Cell Research	2012
Triplex DNA-binding proteins are associated with clinical outcomes revealed by proteomic measurements in patients with colorectal cancer LD Nelson, C Bender, H Mannsperger, D Buergy, P Kambakamba, G Mudduluru, U Korf, D Hughes, MW van Dyke, H Allgayer	Molecular Cancer	2012
Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis W Liu, B Peng, Y Lu, W Xu, W Qian, JY Zhang	Autoimmunity Reviews	2011
A U1-U2 snRNP Interaction Network during Intron Definition W Shao, HS Kim, Y Cao, YZ Xu, CC Query	Molecular and cellular biology	2011
Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors JY Zhang, EM Tan	Expert Review of Molecular Diagnostics	2010
Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers WN Rom, JD Goldberg, D Addrizzo-Harris, HN Watson, M Khilkin, AK Greenberg, DP Naidich, B Crawford, E Eylers, D Liu, EM Tan	BMC Cancer	2010
Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma Y Chen, Y Zhou, S Qiu, K Wang, S Liu, XX Peng, J Li, EM Tan, JY Zhang	Cancer Letters	2010
Genetic Ablation of Caveolin-1 Drives Estrogen-Hypersensitivity and the Development of DCIS-Like Mammary Lesions I Mercier, MC Casimiro, J Zhou, C Wang, C Plymire, KG Bryant, KM Daumer, F Sotgia, G Bonuccelli, AK Witkiewicz, J Lin, TH Tran, J Milliman, PG Frank, JF Jasmin, H Rui, RG Pestell, MP Lisanti	The American Journal of Pathology	2009
Tumor Biomarker Discovery MA Tainsky		2009
Tumor Biomarker Discovery MA Tainsky		2009
Serum autoantibodies as biomarkers for early cancer detection HT Tan, J Low, SG Lim, MC Chung	FEBS Journal	2009
Roles of histone H3-lysine 4 methyltransferase complexes in NR-mediated gene transcription Seunghee Lee, Robert G Roeder, Jae W Lee	Progress in molecular biology and translational science	2009
Autoantibodies to tumor-associated antigens: reporters from the immune system EM Tan, J Zhang	Immunological Reviews	2008
Spatial mapping of splicing factor complexes involved in exon and intron definition JD Ellis, D Llères, M Denegri, AI Lamond, JF Cáceres	The Journal of Cell Biology	2008
Nuclear receptor coactivator/coregulator NCoA6(NRC) is a pleiotropic coregulator involved in transcription, cell survival, growth and development MA Mahajan, HH Samuels	Nuclear receptor signaling	2008
CAPERα Is a Novel Rel-TAD-Interacting Factor That Inhibits Lymphocyte Transformation by the Potent Rel/NF-κB Oncoprotein v-Rel J Dutta, G Fan, C Gélinas	Journal of virology	2008
Mini-array of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of hepatocellular carcinoma JY Zhang	Autoimmunity Reviews	2007
Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma JY Zhang, R Megliorino, XX Peng, EM Tan, Y Chen, EK Chan	Journal of Hepatology	2007
Control of Pre-mRNA Splicing by the General Splicing Factors PUF60 and U2AF65 ML Hastings, E Allemand, DM Duelli, MP Myers, AR Krainer, J Valcarcel	PloS one	2007
Tumor-associated antigen arrays for the serological diagnosis of cancer CA Casiano, M Mediavilla-Varela, EM Tan	Molecular & cellular proteomics : MCP	2006
Steroid Hormone Receptor Coactivation and Alternative RNA Splicing by U2AF65-Related Proteins CAPERα and CAPERβ DH Dowhan, EP Hong, D Auboeuf, AP Dennis, MM Wilson, SM Berget, BW O'Malley	Molecular Cell	2005
Proteomics-based identification of DEAD-box protein 48 as a novel autoantigen, a prospective serum marker for pancreatic cancer Q Xia, XT Kong, GA Zhang, XJ Hou, H Qiang, RQ Zhong	Biochemical and Biophysical Research Communications	2005
A Novel SR-Related Protein Is Required for the Second Step of Pre-mRNA Splicing D Cazalla, K Newton, JF Cáceres	Molecular and cellular biology	2005
Isolation of suppressor genes that restore retrovirus susceptibility to a virus-resistant cell line G Gao, SP Goff	Retrovirology	2004
U2AF homology motifs: protein recognition in the RRM world CL Kielkopf, S Lücke, MR Green	Genes & development	2004
CrELISA: a fast and robust enzyme-linked immunosorbent assay bypassing the need for purification of recombinant protein Ö Türeci, U Luxemburger, H Heinen, U Mack, GW Sybrecht, C Huber, U Sahin	Journal of Immunological Methods	2004
Tumor-associated antigen arrays to enhance antibody detection for cancer diagnosis JY Zhang	Cancer Detection and Prevention	2004
Alternative splicing in disease and therapy MA Garcia-Blanco, AP Baraniak, EL Lasda	Nature Biotechnology	2004
Nuclear Hormone Receptor Coregulator: Role in Hormone Action, Metabolism, Growth, and Development MA Mahajan, HH Samuels	Endocrine reviews	2004
Cancer Diagnostics RM Nakamura, WW Grody, JT Wu, RB Nagle		2004
Relative paradigms between autoantibodies in lupus and autoantibodies in cancer EM Tan, FD Shi	Clinical & Experimental Immunology	2003
Relative paradigms between autoantibodies in lupus and autoantibodies in cancer EM Tan, FD Shi	Clinical & Experimental Immunology	2003
SeroGRID: an improved method for the rapid selection of antigens with disease related immunogenicity P Krause, Ö Türeci, P Micke, R Buhl, C Huber, U Sahin	Journal of Immunological Methods	2003
Treatment of Autoimmune Disorders M Sticherling, E Christophers		2003
A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis FL Naour, F Brichory, DE Misek, C Bréchot, SM Hanash, L Beretta	Molecular & cellular proteomics : MCP	2002
Identification of serum anti-human telomerase reverse transcriptase (hTERT) auto-antibodies during progression to hepatocellular carcinoma K Masutomi, S Kaneko, M Yasukawa, K Arai, S Murakami, K Kobayashi	Oncogene	2002
Autoantibody responses in Chinese hepatocellular carcinoma. Zhang JY, Wang X, Peng XX, Chan EK	Journal of Clinical Immunology	2002
Autoantibodies as reporters igentifying aberrant cellular mechanisms in tumorigenesis Eng Tan	Journal of Clinical Investigation	2001
Autoimmune Responses to mRNA Binding Proteins p62 and Koc in Diverse Malignancies JY Zhang, EK Chan, XX Peng, M Lu, X Wang, F Mueller, EM Tan	Clinical Immunology	2001
De-novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma JY Zhang, W Zhu, H Imai, K Kiyosawa, EK Chan, EM Tan	Clinical & Experimental Immunology	2001
Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies M Abu-Shakra, D Buskila, M Ehrenfeld, K Conrad, Y Shoenfeld	Annals of the rheumatic diseases	2001
Transcription Activating Property of Autoantigen SG2NA and Modulating Effect of WD-40 Repeats W Zhu, EK Chan, J Li, P Hemmerich, EM Tan	Experimental Cell Research	2001
Molecular Cloning and Characterization of CAPER, a Novel Coactivator of Activating Protein-1 and Estrogen Receptors DJ Jung, SY Na, DS Na, JW Lee	The Journal of biological chemistry	2001
Cancer and Autoimmunity O Pritsch, G Dighiero	Cancer and Autoimmunity	2000
Serologic Responses in Patients with Malignant Mesothelioma: Evidence for Both Public and Private Specificities C Robinson, M Callow, S Stevenson, B Scott, BW Robinson, RA Lake	American journal of respiratory cell and molecular biology	2000
Immunology and Liver MP Manns, G Paumgartner, U Leuschner		2000
A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma JY Zhang, EK Chan, XX Peng, EM Tan	Journal of Experimental Medicine	1999
PUF60: a novel U2AF65-related splicing activity PS Page-McCaw, K Amonlirdviman, PA Sharp	RNA (New York, N.Y.)	1999
A Novel Cytoplasmic Protein with RNA-binding Motifs Is an Autoantigen in Human Hepatocellular Carcinoma JY Zhang, EK Chan, XX Peng, EM Tan	Journal of Experimental Medicine	1999
Molecular definition of heterogeneous nuclear ribonucleoprotein R (hnRNP R) using autoimmune antibody: immunological relationship with hnRNP P W Hassfeld, EK Chan, DA Mathison, D Portman, G Dreyfuss, G Steiner, EM Tan	Nucleic Acids Research	1998
Molecular definition of heterogeneous nuclear ribonucleoprotein R (hnRNP R) using autoimmune antibody: Immunological relationship with hnRNP P W Hassfeld, EK Chan, DA Mathison, D Portman, G Dreyfuss, G Steiner, EM Tan	Nucleic Acids Research	1998
Repeat-Induced Point Mutations inPad-1,a Putative RNA Splicing Factor fromNeurospora crassa,Confer Dominant Lethal Effects on Ascus Development GA Kuldau, NB Raju, NL Glass	Fungal Genetics and Biology	1998
Autoantibodies as Chameleons RC Williams, CC Malone, F Silvestris	Scandinavian Journal of Rheumatology	1997
Nuclear Structure and Gene Expression S Penman, BJ Blencowe, JA Nickerson	Nuclear Structure and Gene Expression	1997
Diversity of antinucelar antibody responses in hepatocellular carcinoma G Covini, CA von Mühlen, S Pacchetti, M Colombo, EK Chan, EM Tan	Journal of Hepatology	1997
Autoantibodies MH Lessof, SP Asper	American Heart Journal	1960

Advertisement